• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biocryst Pharma Inc (NQ: BCRX )

    4.205 -0.175 (-4.00%)
    Streaming Delayed Price Updated: 3:00 PM EDT, Apr 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,703,341
    Open 4.370
    Bid (Size) 4.200 (36)
    Ask (Size) 4.210 (93)
    Prev. Close 4.380
    Today's Range 4.180 - 4.420
    52wk Range 4.270 - 9.065
    Shares Outstanding 185,583,896
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
    These penny stocks offer triple digit returns to investors right now but not many investors are aware of them. 
    Via InvestorPlace
    BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
    BCRX earnings call for the period ending December 31, 2023. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial

    Performance

    YTD
    -30.72%
    -30.72%
    1 Month
    -14.36%
    -14.36%
    3 Month
    -23.55%
    -23.55%
    6 Month
    -26.23%
    -26.23%
    1 Year
    -44.74%
    -44.74%

    More News

    Read More
    What's Going On With BioCryst Stock After Earnings?
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    A Preview Of BioCryst Pharma's Earnings
    Via Benzinga
    What's Going On With BioCryst Pharmaceuticals Stock?
    Via Benzinga
    Where BioCryst Pharma Stands With Analysts
    Via Benzinga
    Earnings Scheduled For February 26, 2024
    Via Benzinga
    What 7 Analyst Ratings Have To Say About BioCryst Pharma
    Via Benzinga
    Analyst Expectations for BioCryst Pharma's Future
    Via Benzinga
    Why BioCryst Pharmaceuticals Stock Is Soaring Today
    Via The Motley Fool
    Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth
    Via Benzinga
    BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
    Via Benzinga
    3 Magnificent Growth Stocks to Buy on the Dip
    Via The Motley Fool
    Recap: BioCryst Pharma Q1 Earnings
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
    Via Benzinga
    BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
    Via Benzinga
    BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript
    Via The Motley Fool
    Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?
    Via InvestorPlace
    Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.